Delivery Order SPE2DB22D1106-SPE2DB25FEUC2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,586.41 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 10, 2025, with an ultimate completion date of July 11, 2025. This firm fixed price delivery order represents a non-set-aside competitive award and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management, aligning with...
- The Defense Logistics Agency awarded a delivery order valued at $3,364.00 to AmerisourceBergen Drug Corp for Jardiance 10 mg tablets (90-count packages) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management, consistent...
- The Defense Logistics Agency awarded a delivery order valued at $4,001.08 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on June 2, 2025, with an ultimate completion date of June 3, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription medication commonly used in diabetes management,...
- The Defense Logistics Agency awarded a delivery order valued at $5,508.34 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price delivery order was issued on July 14, 2025, with no set-aside designation, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a widely-used diabetes medication, consistent with...
- The Defense Logistics Agency awarded a delivery order valued at $5,240.80 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed price delivery order represents a non-competitive procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used in military and federal healthcare systems to...
- The Defense Logistics Agency awarded a delivery order valued at $54,904.19 to AmerisourceBergen Drug Corp for 90-tablet supplies of Jardiance 10 mg tablets. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 26, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $2,961.21 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed price delivery order represents a competitively awarded, non-set-aside contract with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $12,196.14 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management, representing...
- The Defense Logistics Agency awarded a delivery order valued at $10,287.08 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used to treat type 2 diabetes and is part of the...
- The Defense Logistics Agency awarded a delivery order valued at $12,468.56 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on July 14, 2025, with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used in military and federal healthcare systems to manage...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEUC2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,143.74 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription diabetes medication commonly used in military and federal healthcare systems to manage type 2 diabetes. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical prime vendor agreement running through December 2026. As a critical pharmaceutical distributor for federal medical procurement, AmerisourceBergen supplies a broad spectrum of medications and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The company's federal contract portfolio demonstrates its established capability to fulfill diverse pharmaceutical requirements through competitive procurement processes with consistent firm fixed-price delivery orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 6/18/25 |